SCHEMBL7795548

SCHEMBL7795548

CCN(CC)Cc1ccccc1.CCNc1ccccc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.43
CNR2 P34972 1/20 0.42
TSHR P16473 2/20 0.42
MAPK1 P28482 1/20 0.42
HRH3 Q9Y5N1 1/20 0.42
BCHE P06276 2/20 0.40
ACHE P22303 1/20 0.40
MEN1 O00255 2/20 0.40
ALDH1A1 P00352 2/20 0.40
KMT2A Q03164 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
CRHR1 P34998 1/20 0.39
HTR1A P08908 1/20 0.39
HTR2C P28335 1/20 0.39
HTR7 P34969 1/20 0.39
HTR2B P41595 1/20 0.39
HTR5A P47898 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7801497 0.86 ALDH1A1 (0.55) KDM4ETSHRMEN1ALDH1A1KMT2A
SCHEMBL1116563 0.81 IDO1 (0.48) KDM4ETSHRMEN1ALDH1A1KMT2A
Trimethylammonium SCHEMBL7802297 0.79 ALDH1A1 (0.45) KDM4EMAPK1MEN1ALDH1A1KMT2A
SCHEMBL7795552 0.78 LMNA (0.46) KDM4ECNR2TSHRMAPK1HRH3
Chloromethane SCHEMBL27279684 0.77 HRH3 (0.60) KDM4ECNR2TSHRMAPK1HRH3
SCHEMBL81248 0.77 HRH3 (0.65) KDM4ECNR2TSHRMAPK1HRH3
SCHEMBL28887965 0.76 IDO1 (0.44) KDM4EMEN1ALDH1A1KMT2ASMN1; SMN2
Water SCHEMBL5507580 0.75 HRH3 (0.62) KDM4ECNR2TSHRMAPK1HRH3
Bromide SCHEMBL11663269 0.75 HRH3 (0.62) KDM4ECNR2TSHRMAPK1HRH3
Iodide SCHEMBL21693881 0.75 HRH3 (0.62) KDM4ECNR2TSHRMAPK1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010012899-A1 Oligomeric methine dyes CLARIANT FINANCE ( BVI) LIMITED 2001-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010012899-A1 Oligomeric methine dyes INMT, DDT, DDC KDM4E 1276/4885CNR2 3039/4885TSHR 3212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.